Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ankyrin repeat domain 20 family member A2, pseudogene (ANKRD20A2P) is a non-protein-coding genomic element classified as a pseudogene on human chromosome 9, belonging to the ankyrin repeat domain-containing gene family[7][8][1][2]. Pseudogenes such as ANKRD20A2P do not produce functional proteins and typically arise through gene duplication or retrotransposition events with subsequent loss of coding potential[7][9]. There is no evidence to support a biological function, disease association, or drug targeting for ANKRD20A2P, and it is specifically noted in genomic databases as a non-functional entity with the caution that it should not be considered a protein target[7][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ankyrin repeat domain 20 family member A2, pseudogene (ANKRD20A2P).